MENU
+Compare
SAFLF
Stock ticker: OTC
AS OF
Jul 9 closing price
Price
$1.29
Change
+$0.53 (+69.74%)
Capitalization
529.04M

SAFLF Safilo Group Spa Forecast, Technical & Fundamental Analysis

Safilo Group SpA makes sunglasses and prescription eyewear... Show more

SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SAFLF with price predictions
Jul 25, 2025

SAFLF's Stochastic Oscillator remains in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SAFLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.190) is normal, around the industry mean (24.533). P/E Ratio (9.074) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.457) is also within normal values, averaging (43.112).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAFLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Settima Strada, 15
Phone
+39 496985111
Employees
4442
Web
https://www.safilogroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMCX17.900.15
+0.85%
Hartford Small Company C
RYHCX86.490.38
+0.44%
Rydex Health Care C
MYSPX68.100.27
+0.40%
NYLI S&P 500 Index Investor Class
EIEMX16.31-0.04
-0.24%
Parametric Emerging Markets I
MIDLX34.66-0.19
-0.55%
MFS International New Discovery R6

SAFLF and Stocks

Correlation & Price change

A.I.dvisor tells us that SAFLF and GMED have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
GMED - SAFLF
28%
Poorly correlated
+2.23%
MYGN - SAFLF
24%
Poorly correlated
-4.30%
JMPHF - SAFLF
23%
Poorly correlated
N/A
OFIX - SAFLF
22%
Poorly correlated
+0.27%
MROPF - SAFLF
21%
Poorly correlated
N/A
More